Search - tctmd.com

Displaying 161 - 180 of 2190

Sort: Relevancy | Date

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

News Conference News AHA 2024

Talking Sex: CVD Patients Want to Hear More From Clinicians

Caitlin E. Cox

November 20, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

Caitlin E. Cox

November 17, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Yael L. Maxwell

November 14, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 13: Chinese Visceral Adiposity Index Is Associated With the Occurrence of Cardiovascular Disease Among Middle-Aged and Older People in China

Presenter: Rongchong Huang

October 29, 2024

Presentation TCT 2024

TCT 240: The Device Success Algorithm of EAPCI Prospectively Applied to the Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in International Multivessel TALENT Randomized Trial

Presenter: Pruthvi C Revaiah

October 28, 2024

Presentation TCT 2024

TCT 292: Prognostic Value of Quantitative Flow Ratio in Patients Undergoing Primary Valve Surgery Combined With Coronary Artery Disease

Presenter: Chenguang Li

October 28, 2024

Presentation TCT 2024

TCT 290: Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the SWEDEHEART Registry

Presenter: Elmir Omerovic

October 28, 2024

News Conference News TCT 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Yael L. Maxwell

October 27, 2024

Presentation TCT 2024

TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

Presenter: IFTIKHAR CH

October 27, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

Advertisement

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Talking Sex: CVD Patients Want to Hear More From Clinicians

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 13: Chinese Visceral Adiposity Index Is Associated With the Occurrence of Cardiovascular Disease Among Middle-Aged and Older People in China

TCT 240: The Device Success Algorithm of EAPCI Prospectively Applied to the Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in International Multivessel TALENT Randomized Trial

TCT 292: Prognostic Value of Quantitative Flow Ratio in Patients Undergoing Primary Valve Surgery Combined With Coronary Artery Disease

TCT 290: Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the SWEDEHEART Registry

Safety Retained When Fellows Lead Complex PCI Procedures

TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

October 2024 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content